Altus Power, Inc. (AMPS) led the pack for Monday’s Penny Stock winners, closing at $4.95, with little movement. Coming in Second behind Atlus were Bluebird Bio, Inc. (BLUE), which closed Monday’s trading at $4.88, up 19.61%, and Asp Isotopes Inc.(ASPI) to round out the top three at $4.69, up roughly fifty cents.
While Atlus won the day on price, its price change came up short against BlueBird. BlueBird, known for gene therapy, closed with a change of plus .80 cents, compared to a one-cent uptick for Atlus Power. All three penny stocks did well considering the market drops and trader woes concerning tariffs that are supposed to take effect this week.
According to reports, U.S. President Donald Trump has deemed April 2 “Liberation Day,” a day on which he plans to roll out tariffs or taxes on imports from other countries. Even with these upcoming changes on the horizon, penny stocks didn’t get shaken.
Penny Stocks: Atlus Power Strikes Luck
Atlus Power, Inc., known for being a commercial-scale provider of clean, electric power, struck for luck in March and released its financial results for its fourth quarter and for the entire year of 2024 on March 17. Among the high points in their press release were:
- Full year 2024 revenues of $196.3 million, a 26% increase compared to full year 2023
- GAAP net loss of $10.7 million for full year 2024, compared to net loss of $26.0 million for full year 2023
- Adjusted EBITDA* of $111.6 million for full year 2024, a 20% increase compared to full year 2023
Traders should also be advised that TPG is currently acquiring Atlas via TPG Rise Climate Transition. When the transaction is complete, the release stated, “…Altus Power’s Class A common stock will no longer be listed or traded on the New York Stock Exchange, and Altus Power will become a privately-held company. ”
“As we move toward our pending acquisition by TPG through its the TPG Rise Climate Transition Infrastructure strategy and transition to a private company, we are positioned to deliver even greater value to our customers and partners with the flexibility and resources to accelerate deployment, drive innovation and expand access to clean energy at scale, ” said Gregg Felton, CEO of Altus Power. Traders are advised to review the March 17 press release regarding further stock information.
Penny Stock Winners (Price Change): Bluebird Bio Inc. Gets Cash Injection
According to a Reuters report, Bluebird Bio’s jump in price may be attributed to a recent press release stating the gene therapy maker was reviewing an offer by Ayrmid, a parent company of cell therapy developer Gamida Cell. The company, reports state, offered to acquire Bluebird for $4.50 per share upfront, totaling more than $40 million. A Business Wire report stated this offer was separate from the reported merger announced in February by Carlyle and SK Capital Partners, LP. According to that report, Bluebird has already entered into a definitive agreement with the global investment firm.
Penny Stock Winners: Asp Isotopes Inc. Announces 4Q Report Release This Week
ASP Isotopes Inc., known as a Development Stage Advanced Materials Company, announced it will release its financial reports at the end of March. As of the evening of March 31, that has not happened. However, traders can keep up with the isotopes producer via their Yahoo! Finance page. Out of the Penny Stock winners for Monday, this will be a “wait and see” type of penny stock.
DISCLAIMER: This content provided by Total Apex Herald is for informational purposes only and should not be considered financial, investment, or legal advice. Every financial situation is unique. We encourage our readers to consult with a licensed financial advisor, accountant, or legal professional before making any financial decisions. Total Apex Herald and its contributors are not responsible for any actions taken based on the information provided in this article.
